Cancers — Editors

Journal Contact

Cancers Editorial Office
MDPI AG, Postfach, CH-4005 Basel, Switzerland
E-Mail: cancers@mdpi.com
Tel. +41 61 683 77 34; Fax: +41 61 302 89 18

Editorial Office

Editor-in-Chief
Prof. Dr. Robert H. Weiss
Division of Nephrology and Cancer Center, University of California, Davis, CA 95616, USA; and Nephrology Section, Sacramento VAMC; and NCI Early Detection Research Network (EDRN), USA
Tel. +1 530 752 4010; Fax: +1 530 752 3791
Website: http://biosci3.ucdavis.edu/FacultyAndResearch/FacultyProfile.aspx?FacultyID=14060
E-Mail: rhweiss@ucdavis.edu
Interests: cyclins and cyclin inhibitors; cancer growth control; metabolomics and proteomics; polycystic kidney disease

Assistant Editor
Ms. Xinya Huang
MDPI Beijing Office, Suite 2011, Ruidu International Center, No. 1 Cuijingbeili, Tongzhou District, Beijing, China
Tel. +86 10 81521170
E-Mail: xinya.huang@mdpi.com

Publisher
Dr. Shu-Kun Lin
MDPI AG, Kandererstrasse 25, CH-4057 Basel, Switzerland
Tel. +41 79 322 33 79
Website: http://www.mdpi.org/lin/
E-Mail: lin@mdpi.com

Editorial Board

Dr. Robert A. Anders
Johns Hopkins School of Medicine, Department of Pathology, Division of GI & Liver Pathology, 1550 Orleans St., Cancer Research Building II Rm 346, Baltimore, Maryland 21231, USA
Tel. +1 410 955 3511; Fax: +1 410 614 0671
Website: http://pathology.jhu.edu/researchbrochure/division.cfm?id=6&#Anders
E-Mail: rander54@jhmi.edu
Interests: liver cancer; hepatitis; bile duct cancer; bile duct development; human liver pathology

Dr. Brigitta G. Baumert
Department of Radiation-Oncology (MAASTRO), Maastricht University Medical Centre (MUMC) and GROW Research Institute, The Netherlands
Website: http://www.maastro.nl/
E-Mail: brigitta.baumert@maastro.nl
Interests: CNS tumors; sarcomas; pet imaging; new MRI imaging techniques introduced for radiation therapy; new international trials in primaruy and secondary brain tumors
Contribution: Special Issue: Cancer Cell Imaging
Special Issue: Re-Irradiation, Chemotherapy, New Drugs for the (Re)-Treatment of Recurrent Gliomas

Dr. Don Benjamin
Growth & Development Unit, Rm. 583 Biozentrum, University of Basel, Klingelbergstrasse 50/70, CH-4056 Basel, Switzerland
Tel. +41 61 267 21 70; Fax: +41 61 267 07 59
E-Mail: don.benjamin@unibas.ch
Interests: mTOR; cancer metabolism; glycolysis; signal transduction; mRNA stability
Contribution: Special Issue: Cancer Signaling Pathways and Crosstalk

Dr. William Chi-shing Cho
Department of Clinical Oncology, Queen Elizabeth Hospital, 30 Gascoigne Road, Kowloon, Hong Kong
Tel. +852 2958 5441; Fax: +852 2958 5455
E-Mail: williamcscho@gmail.com
Interests: cancer biomarker; Chinese medicine; diabetes mellitus; evidence-based medicine; genomics; microRNA; molecular diagnostics; nasopharyngeal carcinoma; non-small cell lung carcinoma; proteomics
Contribution: In other journals:
Special Issue: Advances in Molecular Oncology
Special Issue: Advances in Cancer Diagnosis

Dr. Jonas Cicenas
CALIPHO Group, Swiss Institute of Bioinformatics, CMU - 1, rue Michel Servet, CH-1211 Geneva 4, Switzerland
Tel. +41 22 379 58 74; Fax: +41 22 379 58 58
Website: http://www.mapkinases.eu/founder
E-Mail: j.cicenas@mapkinases.eu
Interests: breast cancer; prostate cancer, acute myeloid leukemia (AML); kinases

Prof. Dr. Robert Coleman
Department of Oncology, Cancer Clinical Trials Centre, Academic Unit of Clinical Oncology, Broomcross Building, Weston Park Hospital, University of Sheffield, Sheffield, S10 2SJ, UK
Tel. +44 114 226 5213; Fax: +44 114 226 5364
Website: http://www.sheffield.ac.uk/medicine/oncology/staffprofiles/coleman.html
E-Mail: r.e.coleman@sheffield.ac.uk
Interests: cancer induced bone disease especially with relevance to breast cancer; the development of bone targeted agents in oncology, evaluation of bone markers in oncology to aid drug development and provide both prognostic and predictive information in the management of metastatic bone disease, and the assessment of adverse effects of cancer treatments on bone health and evaluation of various treatment strategies
Contribution: In other journals:
Special Issue: Prevention and Treatment of Bone Metastases from Breast Cancer

Prof. Dr. Ronald A. DePinho
Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Tel. +1-617-632-6086; Fax: +1-617-632-6069
Website: http://www.uthouston.edu/gsbs/faculty/faculty-directory/faculty-profiles.htm?id=659d3801-32b0-4a3c-a8d1-4df0e0a3d9f7
E-Mail: rdepinho@mdanderson.org
Interests: cancer drug and biomarker development; cancer gene discovery; stem cell biology and development of genetically engineered mouse models to study cancer in humans

Dr. Serenella Eppenberger-Castori
Stiftung Tumorbank Basel, Tumorbank Foundation Basel, Lörracherstr. 50, CH-4125 Riehen, Switzerland
Tel. +41 61 6459304; Fax: +41 61 6459308
E-Mail: s.eppenberger@tumorbank.org
Interests: breast cancer; molecular cancer pathology; prognosis and prediction; bioinformatics and statistics; translational research

Dr. Doriano Fabbro
Executive Director, Expertise Kinase Platforrm, CPC, Novartis Pharma AG, Postfach, CH-4002 Basel, Switzerland
Tel. +41 61 6967681; Fax: +41 61 6967153
E-Mail: doriano.fabbro@novartis.com
Interests: protein kinases regulation; structure; screening and drug discovery

Dr. Salvador Villà Freixa
Department of Radiation Oncology, Hospital Universitari Germans Trías, ICO Badalona, C/Canyet s/n, 08916 Badalona, Catalunya, Spain
E-Mail: svilla@iconcologia.net
Interests: CNS tumours; prostate cancer; sterotactic RT

Dr. Samy L. Habib
1 Department of Cellular and Structural Biology, The University of Texas Health Science Center, San Antonio, TX, USA
2 Geriatric Research, Education and Clinical CTR, South Texas veterans Health System, San Antonio, TX, 78229, USA
Tel. +1 210 567 3816; Fax: +1 210 567 3802
Website: http://www.uthscsa.edu/csb/faculty/habib.asp
E-Mail: habib@uthscsa.edu
Interests: tumor supressor genes; DNA damage and repair pathways; diabetes and cancer; kidney and liver cancer; cell signaling; apoptosis and proliferation; cancer biomakers

Prof. Dr. Jörg Haier
Comprehensive Cancer Center Muenster, International Patient Management, University Hospital Muenster, Waldeyerstr. 1, 48149 Muenster, Germany
Tel. +49 251 83 57630 (Labor 56326); Fax: +49 251 83 57631
Website: http://cccm.uni-muenster.de/
E-Mail: joerg.haier@ukmuenster.de
Interests: gastraintestinal cancer; metastasis; cell adhesion; cell migration; chemotaxis
Contribution: Special Issue: Epigenetics of Cancer Progression
Special Issue: Organ-Specific Metastasis Formation

Prof. Dr. Carl-Henrik Heldin
Ludwig Institute for Cancer Research Ltd., Science for Life Laboratory, Uppsala University, Box 595, Biomedical Center, SE-751 24 Uppsala, Sweden
Tel. +46 18 160401; Fax: +46 18 160420
Website: http://www.licr.uu.se/B_about/
E-Mail: c-h.heldin@licr.uu.se
Interests: growth factors; signal transduction mechanisms; receptors; kinases; angiogenesis

Prof. Dr. W. Martin Kast
Walter A. Richter Cancer Research Chair, Professor of Molecular Microbiology & Immunology, Obstetrics & Gynecology and Urology, Norris Comprehensive Cancer Center (NRT 7507), University of Southern California, 1450 Biggy Street, MC 9601, Los Angeles, CA90033, USA
Tel. +1 323 442 3870; Fax: +1 323 442 7760
Website: http://pibbs.usc.edu/faculty/profile/?fid=236
E-Mail: mkast@usc.edu
Interests: design of HPV immunotherapeutics; developing new and effective therapies for cervical cancer; prostate cancer and melanoma
Contribution: Special Issue: Cancer Vaccines and Immunotherapy

Dr. Charles H. Lawrie
Lymphoid Malignancy Research Group, Nuffield Department of Clinical Laboratory Sciences, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DU, UK
Tel. +44 1865 220344
Website: http://www.intechopen.com/profiles/103158/charles-lawrie
E-Mail: charles.lawrie@ndcls.ox.ac.uk
Interests: cancer; lymphoma; leukemia; microarray; microRNA; biomarkers; non-coding RNA
Contribution: Special Issue: Leukemia

Dr. Chyi-Chia Richard Lee
Laboratory of Pathology, National Cancer Institute, Building 10, Room 2B50, 10 Center Drive, Bethesda, MD 20892, USA
Tel. +1 301 594 7365; Fax: +1 301 480 9488
Website: http://ccr.cancer.gov/staff/staff.asp?profileid=12822
E-Mail: leechy@mail.nih.gov
Interests: melanoma; skin cancers; dermatopathology; skin pathology; melanocytic skin lesions
Contribution: Special Issue: Current Concepts in the Diagnosis and Treatment of Cutaneous Melanoma
Special Issue: Skin Cancer

Dr. Alessandro Lugli
Institute of Pathology, University of Bern, 3010 Bern, Switzerland
Tel. +41 31 632 99 58; Fax: +41 31 632 49 95
E-Mail: alessandro.lugli@pathology.unibe.ch
Interests: gastrointestinal and liver tumors; tumor diagnosis and staging; prognostic and predictive biomarkers
Contribution: Special Issue: Prognostic and Predictive Factors in Colorectal Cancer

Dr. Sauveur-Michel Maira
NIBR Oncology, Novartis Pharma AG, WKL125.12.50, Klybeckstrasse 141, CH-4057 Basel, Switzerland
Tel. +41 61 6967910; Fax: +41 61 6965751
E-Mail: sauveur-michel.maira@novartis.com
Interests: drug discovery; small molecule inhibitors; signaling pathways; predictive biomarkers; response biomarkers

Prof. Dr. Dario Marchetti
Department of Pathology & Immunology, Circulating Tumor Cells (CTC) Core Facility, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
Tel. +1 713 798 2335; Fax: +1 713 798 1956
Website: http://www.bcm.edu/pathimmuno/index.cfm?pmid=13983
E-Mail: marchett@bcm.edu
Interests: mechanisms of brain metastasis; the biology and therapeutic utility of circulating tumor cells (CTCs); the roles of heparanase in development and disease
Contribution: In other journals:
Special Issue: Brain Metastasis

Dr. Enrique A. Mesri
Viral Oncology Research Program, Sylvester Comprehensive Cancer Center, University of Miami AIDS Malignancies Program, Dev. Center for AIDS Research, Department of Microbiology and Immunology, University of Miami, Miller School of Medicine, 1550 NW, 10th Ave, PAP bldg Ste 109B (R138), Miami, FL 33136, USA
Tel. +1 305 243 5659; Fax: +1 305 243 8309
Website: http://chroma.med.miami.edu/micro/faculty_mesri.html
E-Mail: emesri@med.miami.edu
Interests: molecular mechanisms of viral oncogenesis of Kaposi\'s sarcoma; KSHV and AIDS-associated malignancies with an emphasis in translational cancer research; cell signaling, angiogenesis and genomics

Prof. Dr. Alba Minelli
Cellular Biochemistry Unit, Department of Experimental Medicine and Biochemical Sciences, University of Perugia, Via del Giochetto, 06124, Perugia, Italy
Tel. +39 075 7440; Fax: +39 075 7442
E-Mail: aminelli@unipg.it
Interests: prostate cancer; oxidative stress; prostasomes; adenosine
Contribution: Special Issue: Oxidative Stress and Cancer

Dr. Constantine S. Mitsiades
Department of Medical Oncology, Dana-Farber Cancer Institute; and Department of Medicine, Harvard Medical School, 44 Binney Street, Mayer Building, Room M555, Boston, MA 02115, USA
Tel. +1 617 632 1962; Fax: +1 617 812 7701
Website: http://www.dfhcc.harvard.edu/membership/profile/member/485/0/
E-Mail: constantine_mitsiades@dfci.harvard.edu
Interests: hematologic malignancies; novel therapeutics; signal transduction inhibitors; tumor microenvironment; bone metastases; clinical trial design; prognostic markers; multiple myeloma; plasma cell dyscrasias; insulin-like growth factor; IGF1R; heat shock protein; proteasome; histone deacetylase; kinase
Contribution: Special Issue: Tumor Cell Genesis and Its Microenvironment: Chicken or the Egg

Prof. Dr. Margareta Mueller
Head, Molecular Cell Biology Laboratory, Hochschule Furtwangen University, Campus Villingen-Schwenningen, Jakob Kienzle Str 17, 78054 Villingen-Schwenningen, Germany
Tel. +49 7720 307 4231; Fax: +49 7720 307 4207
E-Mail: muem@hs-furtwangen.de
Interests: tumor stroma interaction; angiogenesis; inflammation and cancer; growth factors and cytokines; proteases; IL-6 signalling
Contribution: Special Issue: Tumor Cell Genesis and Its Microenvironment: Chicken or the Egg

Prof. Dr. Hasan Mukhtar
Department of Dermatology, University of Wisconsin, Medical Science Center, Rm 4385, 1300 University Avenue, Madison, WI 53706,USA
Tel. +1 608 263 3927; Fax: +1 608 263 5223
Website: http://www.dermatology.wisc.edu/mukhtar.htm
E-Mail: hmukhtar@dermatology.wisc.edu
Interests: apoptosis; chemical carcinogenesis; chemoprevention, cytochrome P450; metabolic basis of toxicity; photocarcinogenesis; tumor promotion/prevention

Prof. Dr. Akira Nakagawara
Chiba Cancer Center, Director of Research Institute; and Division of Biochemistry and Innovative Cancer Therapeutics, 666-2 Nitona, Chuo-ku, Chiba 260-8717, Japan
Tel. +81 43 264 5431; Fax: +81 43 263 8175
Website: http://www.chiba-cc.jp/test/inst/eng/organization/personal/001.html
E-Mail: akiranak@chiba-cc.jp
Interests: molecular biology of cancer; neuroblastoma and neural development

Prof. Dr. Masanobu Oshima
Division of Genetics, Cancer Research Institute, Kanazawa University, Kakuma-machi, Kanazawa 920-1192, Japan
Tel. +81-76-264-6760; Fax: +81-76-234-4519
E-Mail: oshimam@staff.kanazawa-u.ac.jp
Interests: cancer genetics; molecular pathology of gastrointestinal cancers; cancer stem cell and Wnt signaling
Contribution: Special Issue: Exploring Inflammation in Cancers

Dr. George Pentheroudakis
Medical Oncologist, Department of Medical Oncology, Ioannina University Hospital, Greece
E-Mail: gpenther@cc.uoi.gr
Interests: GI cancer; cancer of unknown primary; cancer and pregnancy; adolescent/young adult oncology and phase I/pharmacokinetic studies of investigational agents

Prof. Dr. Sven Perner
Institute of Pathology, University Hospital of Bonn, Sigmund-Freud-Str. 25, 53127 Bonn, Germany
Tel. +49 228 287 15323; Fax: +49 228 287 9080019
Website: http://www.pernerlab.de/mitarbeiter/sven_perner.htm
E-Mail: sven.perner1972@gmail.com
Interests: understanding of the molecular biology of prostate cancer and the development of predictive biomarkers; genetics; molecular biology; TMPRSS2-ERG gene fusion; gene translocations; biomarker development
Contribution: Special Issue: Prostate Cancer

Dr. Christian Pilarsky
Klinik und Poliklinik für Viszeral-, Thorax- und Gefäßchirurgie, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Fetscherstraße 74, 01307 Dresden, Germany
Tel. +49 351 458 166 07; Fax: +49 351 449 210 303
Website: http://www.uniklinikum-dresden.de/das-klinikum/kliniken-polikliniken-institute/vtg/forschung/pankreasforschung/pd-dr-christian-pilarsky
E-Mail: christian.pilarsky@uniklinikum-dresden.de
Interests: pancreas cancer; apoptosis; microarrays; signal transduction networks; tumor stroma interaction; prostate cancer; biomarker
Contribution: Special Issue: Pancreatic Cancer

Prof. Dr. Dirk Rades
Department of Radiation Oncology, University of Lübeck, UK-SH Campus Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany
Tel. +49 451 5006661; Fax: +49 451 5003324
Website: http://www.strahlentherapie-lübeck.de/
E-Mail: dirk.rades@uk-sh.de
Interests: radiation oncology; metastases; radiochemotherapy; CNS tumors; head and neck cancer; gastrointestinal cancer

Dr. Michael W. Retsky
Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA
Tel. +1 203 675 0017
Website: http://connects.catalyst.harvard.edu/PROFILES/ProfileDetails.aspx?Person=MWR2
E-Mail: michael.retsky@gmail.com
Interests: cancer research; electron beam technology
Contribution: Special Issue: Surgery Induced Tumorigenesis in Breast and Other Cancers: An Inconvenient Truth?
In other journals:
Special Issue: Neural Networks and Sensors
Special Issue: Neural Networks and Sensors

Prof. Dr. Afshin Samali
Director of Apoptosis Research Centre, School of Natural Sciences, National University of Ireland - Galway, University Road, Galway, Ireland
Tel. +353 91 492440; Fax: +353 91 494596
Website: http://www.nuigalway.ie/biochemistry/staff/samali/index.html
E-Mail: afshin.samali@nuigalway.ie
Interests: apoptosis; cell death; autophagy; TRAIL; heat shock proteins; Endoplasmic Reticulum stress; hypoxia
Contribution: Special Issue: Cell Death and Cancer

Dr. Thomas D. Schmittgen
Division of Pharmaceutics, College of Pharmacy, Ohio State University, Parks Hall, 500 West 12th Avenue, Columbus, OH 43210, USA
Tel. +1 614 292 3456; Fax: +1 614 292 7766
Website: http://www.pharmacy.ohio-state.edu/programs/ceut/faculty/schmittgen/
E-Mail: schmittgen.2@osu.edu
Interests: noncoding RNA; microRNA; cancer; quantitative RT-PCR; pancreatic cancer

Prof. Dr. Roderich E. Schwarz
Goshen Center for Cancer Care, Indiana University Health, 200 High Park Ave., Goshen, IN 46526, USA
Tel. +1-574-364-2892; Fax: +1-574-364-2480
Website: http://iuhealth.org/goshen/cancer-care/our-team/roderich-e-schwarz-md-phd-facs/
E-Mail: RSchwarz@iuhealth.org
Interests: bile duct cancer; gastric cancer; liver cancer; pancreatic cancer
Contribution: Special Issue: Gastric Cancer

Prof. Dr. Sandip Kumar SenGupta
Department of Pathology & Molecular Medicine, Queen's University, Canada
Tel. +1 613 549 6666 ext. 4164; Fax: +1 613 548 6076
E-Mail: sengupts@kgh.kari.net
Interests: breast cancer pathology; immunohistochemistry; prognostic and predictive factors; biomarkers
Contribution: Special Issue: Breast Cancers: Pathology and Biomarkers

Dr. Giulio C. Spagnoli
Laboratory of Oncology, Institute of Surgical Research and Hospital Management, University of Basel, c/o ZLF, Hebelstrasse 20, CH-4031 Basel, Switzerland
Tel. +1 (0)61 265 2378
Website: http://biomedizin.unibas.ch/nc/about-us/people/profil/profile/person/spagnoli/
E-Mail: gspagnoli@uhbs.ch
Interests: tumor immunology; cellular immunology; cancer cell biology

Dr. Eike Staub
Drug Discovery Informatics, Merck Serono Research & Development, Merck KGaA, Darmstadt, Germany; Lecturer of Bioinformatics, Hochschule Darmstadt and Hochschule Mannheim, Germany
Tel. +49 6151 725989; Fax: +49 6151 723329
E-Mail: eike.staub@merck.de
Interests: cancer drug target identification and validation; cancer drug discovery; oncogenomics for preclinical models & for patient stratification; bioinformatics for prediction of disease genes; analysis of protein, gene and genome evolution

Dr. Tomoharu Sugie
Breast Surgery, Kyoto University Hospital, 54 Shogoin Kawara-cho, Sakyo-ku, Kyoto 606-8507, Japan
Tel. +81 75 751 3660; Fax: +81 75 751 3616
E-Mail: sugie@kuhp.kyoto-u.ac.jp
Interests: breast surgery; cancer immunology
Contribution: Special Issue: Breast Cancer

Dr. Ugo Testa
Medical Oncology Section, Department of Hematology and Oncology, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy
Tel. +39 06 4990 2422
Website: http://www.iss.it/site/attivita/ISSWEB_istituto/RicercaPersonale/dettaglio.asp?idAna=1239&lang=1
E-Mail: ugo.testa@iss.it

Dr. Kwong Yok Tsang
Cellular Immunology Group, Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive, MSC-1750, Building 10, Room 8B08, Bethesda, MD 20892, USA
Tel. +1 301 496 9694; Fax: +1 301 496 2756
Website: http://ccr.cancer.gov/Labs/Lab.asp?LabID=39
E-Mail: kt84c@nih.gov
Interests: the role of the human immune response to tumor-associated antigens. We are working to define and develop immunodominant determinants and modifications of those determinants toward the optimal activation of human immune responses to tumor-associated antigens. Additionally, we are involved in studying mechanisms to enhance the potency of antigen-presenting cells for specific T cell activation. We are also developing immunologic methods and immunoassays to better define the efficacy of vaccine therapies for a range of human cancers.
Contribution: Special Issue: Immune Responses to Human Prostate Cancer

Dr. Asad Umar
Gastrointestinal & Other Cancers Research Group, Division of Cancer Prevention, National Cancer Institute, 6130 Executive Blvd, EPN2142, Rockville, MD 20852, USA
Tel. +1 301 594 2684; Fax: +1 301 435 6344
E-Mail: asad.umar@nih.gov
Interests: gastrointestinal; skin, and hematolymphoid cancers prevention policies and future research directions

Dr. Guillermo Velasco
Department of Biochemistry and Molecular Biology I, School of Biology, Complutense University, C/José Antonio Nováis nº 2, 28040 Madrid, Spain
Tel. +34 913944668; Fax: +34 913944672
Website: https://solea.quim.ucm.es/cannabis/guillermovelascoinicio_en.htm
E-Mail: gvd@solea.quim.ucm.es
Interests: autophagy; ER stress; gliomas; cannabinoid antitumoral action; ceramide signaling
Contribution: Special Issue: Autophagy and Cancer

Prof. Dr. Xiao Yan Zhong
Department of Biomedicine, University Hospital Basel, Hebelstrasse 20, CH-4031 Basel, Switzerland
Tel. +41 61 328 69 86
Website: http://biomedizin.unibas.ch/nc/about-us/people/profil/profile/person/zhong/
E-Mail: xzhong@uhbs.ch
Interests: women’s health: non invasive prenatal diagnosis and tumor marker’s in gynecologic cancer

Dr. Penghui Zhou
Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave., Boston, MA 02115, USA
Tel. +1 617 632 4176
Website: http://connects.catalyst.harvard.edu/profiles/profile/person/97237
E-Mail: Penghui_zhou@dfci.harvard.edu
Interests: Cancer immunology; T cell therapy

Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert